Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
40.9M
-
Shares change
-
+4.11M
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
+$210M
-
Put/Call ratio
-
0.81
-
Number of buys
-
107
-
Number of sells
-
-92
-
Price
-
$45.60
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2017
248 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2017.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.9M shares
of 44.9M outstanding shares and own 91.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.18M shares), VANGUARD GROUP INC (2.86M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.44M shares), Partner Fund Management, L.P. (1.63M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.61M shares), Alyeska Investment Group, L.P. (1.41M shares), GILDER GAGNON HOWE & CO LLC (1.22M shares), PointState Capital LP (1.21M shares), DARUMA CAPITAL MANAGEMENT LLC (1.16M shares), and STATE STREET CORP (1.11M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.